Cell-Surface Heparan Sulfate Proteoglycans Are Essential Components of the Unconventional Export Machinery of FGF-2
Zehe, Christoph, Engling, André, Wegehingel, Sabine, Schäfer, Tobias, Nickel, Walter
Published in Proceedings of the National Academy of Sciences - PNAS (17.10.2006)
Published in Proceedings of the National Academy of Sciences - PNAS (17.10.2006)
Get full text
Journal Article
Biosynthetic FGF-2 is targeted to non-lipid raft microdomains following translocation to the extracellular surface of CHO cells
Engling, André, Backhaus, Rafael, Stegmayer, Carolin, Zehe, Christoph, Seelenmeyer, Claudia, Kehlenbach, Angelika, Schwappach, Blanche, Wegehingel, Sabine, Nickel, Walter
Published in Journal of cell science (15.09.2002)
Published in Journal of cell science (15.09.2002)
Get full text
Journal Article
A specific CD4 epitope bound by tregalizumab mediates activation of regulatory T cells by a unique signaling pathway
Helling, Bianca, König, Martin, Dälken, Benjamin, Engling, Andre, Krömer, Wolfgang, Heim, Katharina, Wallmeier, Holger, Haas, Jürgen, Wildemann, Brigitte, Fritz, Brigitte, Jonuleit, Helmut, Kubach, Jan, Dingermann, Theodor, Radeke, Heinfried H, Osterroth, Frank, Uherek, Christoph, Czeloth, Niklas, Schüttrumpf, Jörg
Published in Immunology and cell biology (01.04.2015)
Published in Immunology and cell biology (01.04.2015)
Get full text
Journal Article
High thioredoxin‐1 levels in rheumatoid arthritis patients diminish binding and signalling of the monoclonal antibody Tregalizumab
Heim, Katharina, Dälken, Benjamin, Faust, Stefanie, Rharbaoui, Faiza, Engling, Andre, Wallmeier, Holger, Dingermann, Theodor, Radeke, Heinfried H, Schüttrumpf, Jörg, Gutscher, Marcus
Published in Clinical & translational immunology (01.12.2016)
Published in Clinical & translational immunology (01.12.2016)
Get full text
Journal Article
BT062, An Antibody-Drug Conjugate Directed Against CD138, Shows Clinical Activity in Patients with Relapsed or Relapsed/Refractory Multiple Myeloma
Jagannath, Sundar, Chanan-Khan, Asher, Heffner, Leonard T., Avigan, David, Zimmerman, Todd M., Lonial, Sagar, Lutz, Robert J., Engling, Andre, Uherek, Christoph, Osterroth, Frank, Ruehle, Markus, Beelitz, Michelle A., Niemann, Gabriele, Wartenberg-Demand, Andrea, Haeder, Thomas, Anderson, Kenneth C., Munshi, Nikhil C.
Published in Blood (18.11.2011)
Published in Blood (18.11.2011)
Get full text
Journal Article
USES OF IMMUNOCONJUGATES TARGETING CD138
BRUECHER CHRISTOPH, NIEMANN GABRIELE, ZUBER CHANTAL, SCHULZ GREGOR, WARTENBERG DEMAND ANDREA, GUTSCHER MARCUS, OSTERROTH FRANK, HAEDER THOMAS, ENGLING ANDRE, KOENIG MARTIN, DAELKEN BENJAMIN, UHEREK CHRISTOPH, BERNOESTER KATRIN
Year of Publication 14.08.2014
Get full text
Year of Publication 14.08.2014
Patent
AGENTS FOR TREATING DISEASE
DAELKEN BENJAMIN, UHEREK CHRISTOPH, CZELOTH NIKLAS, WALLMEIER HOLGER, VOELP KIRSTEN, BRUECHER CHRISTOPH, ZUBER CHANTAL, SCHULZ GREGOR, OSTERROTH FRANK, ENGLING ANDRE
Year of Publication 18.09.2012
Get full text
Year of Publication 18.09.2012
Patent
HUMANIZED ANTI-IL-10 ANTIBODIES FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
DAELKEN BENJAMIN, ROETTGEN PETER, UHEREK CHRISTOPH, CZELOTH NIKLAS, BRUECHER CHRISTOPH, ZUBER CHANTAL, WARTENBERG DEMAND ANDREA, GUTSCHER MARCUS, OSTERROTH FRANK, ENGLING ANDRE, WESSELS KRANZ JUDITH
Year of Publication 19.09.2012
Get full text
Year of Publication 19.09.2012
Patent
USES OF IMMUNOCONJUGATES TARGETING CD138
CZELOTH NIKLAS, BRUECHER CHRISTOPH, NIEMANN GABRIELE, ZUBER CHANTAL, WARTENBERG DEMAND ANDREA, SCHULZ GREGOR, OSTERROTH FRANK, ENGLING ANDRE, HAEDER THOMAS, DAELKEN BENJAMIN, UHEREK CHRISTOPH, ZENG STEFFEN, AIGNER SILKE
Year of Publication 11.05.2012
Get full text
Year of Publication 11.05.2012
Patent
USES OF IMMUNOCONJUGATES TARGETING CD138
Zuber, Chantal, Koenig, Martin, Haeder, Thomas, Gutscher, Marcus, Niemann, Gabriele, Daelken, Benjamin, Wartenberg-Demand, Andrea, Osterroth, Frank, Engling, Andre, Schulz, Gregor, Bruecher, Christoph, Uherek, Christoph, Bernoester, Katrin
Year of Publication 25.04.2019
Get full text
Year of Publication 25.04.2019
Patent
Uses of immunoconjugates targeting CD138
Zuber, Chantal, Koenig, Martin, Haeder, Thomas, Gutscher, Marcus, Niemann, Gabriele, Daelken, Benjamin, Wartenberg-Demand, Andrea, Osterroth, Frank, Engling, Andre, Schulz, Gregor, Bruecher, Christoph, Uherek, Christoph, Bernoester, Katrin
Year of Publication 06.11.2018
Get full text
Year of Publication 06.11.2018
Patent
USES OF IMMUNOCONJUGATES TARGETING CD138
BRUECHER, Christoph, GUTSCHER, Marcus, WARTENBERG-DEMAND, Andrea, BERNOESTER, Katrin, SCHULZ, Gregor, ENGLING, Andre, NIEMANN, Gabriele, ZUBER, Chantal, UHEREK, Christoph, OSTERROTH, Frank, KOENIG, Martin, HAEDER, Thomas, DAELKEN, Benjamin
Year of Publication 20.06.2018
Get full text
Year of Publication 20.06.2018
Patent
AGENTS FOR TREATING DISEASE
VOLP KIRSTEN, DAELKEN BENJAMIN, UHEREK CHRISTOPH, CZELOTH NIKLAS, WALLMEIER HOLGER, BRUECHER CHRISTOPH, ZUBER CHANTAL, SCHULZ GREGOR, ENGLING ANDRE, OSTERROTH FRANK
Year of Publication 29.06.2016
Get full text
Year of Publication 29.06.2016
Patent
método para tratar uma doença, e, kit
ANDRE ENGLING, MARTIN KOENIG, GABRIELE NIEMANN, CHRISTOPH UHEREK, THOMAS HAEDER, MARCUS GUTSCHER, BENJAMIN DAELKEN, GREGOR SCHULZ, CHRISTOPH BRUECHER, KATRIN BERNOESTER, FRANK OSTERROTH, CHANTAL ZUBER, ANDREA WARTENBERG-DEMAND
Year of Publication 13.06.2017
Get full text
Year of Publication 13.06.2017
Patent